Comparing the Therapeutic Efficacy of Intradermal Injection of Platelet-Rich Plasma and Topical Application of Hydroquinone 2% in Melasma Treatment
Nada, H., Ismail, N., Abd El Hady, S., Mohamed, A. (2023). Comparing the Therapeutic Efficacy of Intradermal Injection of Platelet-Rich Plasma and Topical Application of Hydroquinone 2% in Melasma Treatment. EKB Journal Management System, 26(7), 0-0. doi: 10.21608/scumj.2023.309138
Hesham A. Nada; Nader A. Ismail; Shaymaa A. Abd El Hady; Aya F. Mohamed. "Comparing the Therapeutic Efficacy of Intradermal Injection of Platelet-Rich Plasma and Topical Application of Hydroquinone 2% in Melasma Treatment". EKB Journal Management System, 26, 7, 2023, 0-0. doi: 10.21608/scumj.2023.309138
Nada, H., Ismail, N., Abd El Hady, S., Mohamed, A. (2023). 'Comparing the Therapeutic Efficacy of Intradermal Injection of Platelet-Rich Plasma and Topical Application of Hydroquinone 2% in Melasma Treatment', EKB Journal Management System, 26(7), pp. 0-0. doi: 10.21608/scumj.2023.309138
Nada, H., Ismail, N., Abd El Hady, S., Mohamed, A. Comparing the Therapeutic Efficacy of Intradermal Injection of Platelet-Rich Plasma and Topical Application of Hydroquinone 2% in Melasma Treatment. EKB Journal Management System, 2023; 26(7): 0-0. doi: 10.21608/scumj.2023.309138

Comparing the Therapeutic Efficacy of Intradermal Injection of Platelet-Rich Plasma and Topical Application of Hydroquinone 2% in Melasma Treatment

Suez Canal University Medical Journal
Article 4, Volume 26, Issue 7, July 2023, Page 0-0  XML
Document Type: Original Article
DOI: 10.21608/scumj.2023.309138
View on SCiNiTO View on SCiNiTO
Authors
Hesham A. Nada1; Nader A. Ismail1; Shaymaa A. Abd El Hady2; Aya F. Mohamed email 3
1Department of Dermatology, Venerology, and Andrology, Faculty of Medicine, Suez Canal University, Egypt
2Department Clinical Pathology, Faculty of Medicine, Suez Canal University, Egypt
3Department of Dermatology, Ismailia Health Directorate, Egypt
Abstract
Background: Melasma is a condition that causes the skin to get darker over time. There have been several therapies for melasma that have had mixed effects. Objective: To compare two therapeutic modalities for melasma; topical hydroquinone 2 percent and intradermal injection of PRP. Methods: Acase-control study of 60 mixed melasma female patients with Fitzpatrick skin types II, III, and IV was conducted. The patients were then separated into two groups: group (1) was treated with intradermal PRP injections for four sessions every three weeks, while Group (2) was treated with topical hydroquinone 2 percent for nine weeks. The % decrease in baseline MASI score and digital photography were used to evaluate the results. Results: MASI score was calculated at (0, 3, 6, 9 weeks) and after the last session by one month. PRP group and the Hydroquinone group were significantly different regarding the changes in the mean score of MASI score at week 13 of the study (P = 0.002). The mean MASI score was reduced by 54.79% in the PRP group and 24.52% in the hydroquinone group at week 13. Conclusion: Melasma may benefit from the use of platelet-rich plasma as an alternative therapy.
 
Keywords
Melasma; Platelet-rich plasma; Hydroquinone
Statistics
Article View: 140